Brenda Vincenzi, MD, is a physician and drug development leader with deep expertise in neurodevelopmental and psychiatric disorders. Prior to joining Oak Hill Bio, Dr. Vincenzi held senior leadership roles at uniQure, and at Hoffmann-La Roche , where she led global clinical development efforts in neuroscience. Her work included programs in Angelman syndrome, autism spectrum disorder, and psychiatric conditions, spanning early- to late-stage development. Dr. Vincenzi began her career in academic medicine, holding clinical and research positions at institutions including Massachusetts General Hospital and neuropsychiatric centers in the United Kingdom and Switzerland. Dr. Vincenzi received her MD and completed her residency in Child and Adolescent Neuropsychiatry at the University of Verona.